nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—Hexylcaine—SCN10A—melanoma	0.00655	1	CrCbGaD
Dexmethylphenidate—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A11—melanoma	0.00327	0.0589	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A11—melanoma	0.00289	0.0522	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Dopaminergic Neurogenesis—CDKN1C—melanoma	0.00251	0.0453	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Amine compound SLC transporters—SLC6A11—melanoma	0.00227	0.0409	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Amine compound SLC transporters—SLC6A11—melanoma	0.00201	0.0362	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Serotonin Transporter Activity—ITGB3—melanoma	0.00189	0.034	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—SLC39A12—melanoma	0.00162	0.0292	CbGpPWpGaD
Dexmethylphenidate—Angiopathy—Temozolomide—melanoma	0.00142	0.00152	CcSEcCtD
Dexmethylphenidate—Mental disorder—Carmustine—melanoma	0.00142	0.00152	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Temozolomide—melanoma	0.00142	0.00151	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Temozolomide—melanoma	0.00141	0.00151	CcSEcCtD
Dexmethylphenidate—Erythema—Carmustine—melanoma	0.00141	0.00151	CcSEcCtD
Dexmethylphenidate—Malnutrition—Carmustine—melanoma	0.00141	0.00151	CcSEcCtD
Dexmethylphenidate—Cough—Bleomycin—melanoma	0.00141	0.00151	CcSEcCtD
Dexmethylphenidate—Chills—Temozolomide—melanoma	0.00141	0.0015	CcSEcCtD
Dexmethylphenidate—Dehydration—Docetaxel—melanoma	0.0014	0.0015	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Dactinomycin—melanoma	0.0014	0.00149	CcSEcCtD
Dexmethylphenidate—Anaemia—Dactinomycin—melanoma	0.0014	0.00149	CcSEcCtD
Dexmethylphenidate—Liver function test abnormal—Docetaxel—melanoma	0.00139	0.00148	CcSEcCtD
Dexmethylphenidate—SLC6A2—NRF2 pathway—SLC39A12—melanoma	0.00139	0.0251	CbGpPWpGaD
Dexmethylphenidate—Vomiting—Vemurafenib—melanoma	0.00139	0.00148	CcSEcCtD
Dexmethylphenidate—Alopecia—Temozolomide—melanoma	0.00139	0.00148	CcSEcCtD
Dexmethylphenidate—Chest pain—Bleomycin—melanoma	0.00138	0.00147	CcSEcCtD
Dexmethylphenidate—Myalgia—Bleomycin—melanoma	0.00138	0.00147	CcSEcCtD
Dexmethylphenidate—Abdominal pain upper—Docetaxel—melanoma	0.00138	0.00147	CcSEcCtD
Dexmethylphenidate—Rash—Vemurafenib—melanoma	0.00138	0.00147	CcSEcCtD
Dexmethylphenidate—Mental disorder—Temozolomide—melanoma	0.00137	0.00147	CcSEcCtD
Dexmethylphenidate—Dermatitis—Vemurafenib—melanoma	0.00137	0.00147	CcSEcCtD
Dexmethylphenidate—Back pain—Carmustine—melanoma	0.00137	0.00146	CcSEcCtD
Dexmethylphenidate—Headache—Vemurafenib—melanoma	0.00137	0.00146	CcSEcCtD
Dexmethylphenidate—Malnutrition—Temozolomide—melanoma	0.00137	0.00146	CcSEcCtD
Dexmethylphenidate—Erythema—Temozolomide—melanoma	0.00137	0.00146	CcSEcCtD
Dexmethylphenidate—Breast disorder—Docetaxel—melanoma	0.00136	0.00145	CcSEcCtD
Dexmethylphenidate—Discomfort—Bleomycin—melanoma	0.00136	0.00145	CcSEcCtD
Dexmethylphenidate—Malaise—Dactinomycin—melanoma	0.00136	0.00145	CcSEcCtD
Dexmethylphenidate—Cramp muscle—Docetaxel—melanoma	0.00136	0.00145	CcSEcCtD
Dexmethylphenidate—Leukopenia—Dactinomycin—melanoma	0.00135	0.00144	CcSEcCtD
Dexmethylphenidate—Nasopharyngitis—Docetaxel—melanoma	0.00135	0.00144	CcSEcCtD
Dexmethylphenidate—Confusional state—Bleomycin—melanoma	0.00133	0.00142	CcSEcCtD
Dexmethylphenidate—Vision blurred—Carmustine—melanoma	0.00133	0.00142	CcSEcCtD
Dexmethylphenidate—Alanine aminotransferase increased—Docetaxel—melanoma	0.00133	0.00142	CcSEcCtD
Dexmethylphenidate—Tremor—Carmustine—melanoma	0.00132	0.00141	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Bleomycin—melanoma	0.00132	0.00141	CcSEcCtD
Dexmethylphenidate—Oedema—Bleomycin—melanoma	0.00132	0.00141	CcSEcCtD
Dexmethylphenidate—Back pain—Temozolomide—melanoma	0.00132	0.00141	CcSEcCtD
Dexmethylphenidate—Infection—Bleomycin—melanoma	0.00131	0.0014	CcSEcCtD
Dexmethylphenidate—Anaemia—Carmustine—melanoma	0.00131	0.00139	CcSEcCtD
Dexmethylphenidate—Agitation—Carmustine—melanoma	0.0013	0.00138	CcSEcCtD
Dexmethylphenidate—Nausea—Vemurafenib—melanoma	0.0013	0.00138	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Bleomycin—melanoma	0.00129	0.00138	CcSEcCtD
Dexmethylphenidate—Vision blurred—Temozolomide—melanoma	0.00129	0.00137	CcSEcCtD
Dexmethylphenidate—Myalgia—Dactinomycin—melanoma	0.00129	0.00137	CcSEcCtD
Dexmethylphenidate—Tremor—Temozolomide—melanoma	0.00128	0.00136	CcSEcCtD
Dexmethylphenidate—Discomfort—Dactinomycin—melanoma	0.00127	0.00135	CcSEcCtD
Dexmethylphenidate—Angina pectoris—Docetaxel—melanoma	0.00127	0.00135	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Temozolomide—melanoma	0.00127	0.00135	CcSEcCtD
Dexmethylphenidate—Leukopenia—Carmustine—melanoma	0.00127	0.00135	CcSEcCtD
Dexmethylphenidate—Anaemia—Temozolomide—melanoma	0.00126	0.00135	CcSEcCtD
Dexmethylphenidate—Anorexia—Bleomycin—melanoma	0.00126	0.00134	CcSEcCtD
Dexmethylphenidate—Agitation—Temozolomide—melanoma	0.00126	0.00134	CcSEcCtD
Dexmethylphenidate—Angioedema—Temozolomide—melanoma	0.00125	0.00133	CcSEcCtD
Dexmethylphenidate—Pancytopenia—Docetaxel—melanoma	0.00124	0.00132	CcSEcCtD
Dexmethylphenidate—SLC6A3—NRF2 pathway—SLC39A12—melanoma	0.00123	0.0222	CbGpPWpGaD
Dexmethylphenidate—Oedema—Dactinomycin—melanoma	0.00123	0.00131	CcSEcCtD
Dexmethylphenidate—Malaise—Temozolomide—melanoma	0.00123	0.00131	CcSEcCtD
Dexmethylphenidate—Vertigo—Temozolomide—melanoma	0.00123	0.00131	CcSEcCtD
Dexmethylphenidate—Convulsion—Carmustine—melanoma	0.00122	0.00131	CcSEcCtD
Dexmethylphenidate—Infection—Dactinomycin—melanoma	0.00122	0.00131	CcSEcCtD
Dexmethylphenidate—Leukopenia—Temozolomide—melanoma	0.00122	0.0013	CcSEcCtD
Dexmethylphenidate—Hypertension—Carmustine—melanoma	0.00122	0.0013	CcSEcCtD
Dexmethylphenidate—Palpitations—Temozolomide—melanoma	0.00121	0.00129	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Dactinomycin—melanoma	0.00121	0.00129	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Bleomycin—melanoma	0.0012	0.00128	CcSEcCtD
Dexmethylphenidate—Chest pain—Carmustine—melanoma	0.0012	0.00128	CcSEcCtD
Dexmethylphenidate—Myalgia—Carmustine—melanoma	0.0012	0.00128	CcSEcCtD
Dexmethylphenidate—Anxiety—Carmustine—melanoma	0.0012	0.00128	CcSEcCtD
Dexmethylphenidate—Cough—Temozolomide—melanoma	0.00119	0.00127	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Bleomycin—melanoma	0.00119	0.00127	CcSEcCtD
Dexmethylphenidate—Weight increased—Docetaxel—melanoma	0.00119	0.00126	CcSEcCtD
Dexmethylphenidate—Convulsion—Temozolomide—melanoma	0.00118	0.00126	CcSEcCtD
Dexmethylphenidate—Weight decreased—Docetaxel—melanoma	0.00118	0.00126	CcSEcCtD
Dexmethylphenidate—Hypertension—Temozolomide—melanoma	0.00118	0.00126	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Bleomycin—melanoma	0.00118	0.00126	CcSEcCtD
Dexmethylphenidate—Anorexia—Dactinomycin—melanoma	0.00117	0.00125	CcSEcCtD
Dexmethylphenidate—Pneumonia—Docetaxel—melanoma	0.00117	0.00125	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—POU3F2—melanoma	0.00116	0.021	CbGpPWpGaD
Dexmethylphenidate—Confusional state—Carmustine—melanoma	0.00116	0.00124	CcSEcCtD
Dexmethylphenidate—Myalgia—Temozolomide—melanoma	0.00116	0.00124	CcSEcCtD
Dexmethylphenidate—Arthralgia—Temozolomide—melanoma	0.00116	0.00124	CcSEcCtD
Dexmethylphenidate—Infestation—Docetaxel—melanoma	0.00116	0.00124	CcSEcCtD
Dexmethylphenidate—Infestation NOS—Docetaxel—melanoma	0.00116	0.00124	CcSEcCtD
Dexmethylphenidate—Anxiety—Temozolomide—melanoma	0.00116	0.00124	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00115	0.00123	CcSEcCtD
Dexmethylphenidate—Oedema—Carmustine—melanoma	0.00115	0.00123	CcSEcCtD
Dexmethylphenidate—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00115	0.00123	CcSEcCtD
Dexmethylphenidate—Discomfort—Temozolomide—melanoma	0.00115	0.00123	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Bleomycin—melanoma	0.00115	0.00122	CcSEcCtD
Dexmethylphenidate—Infection—Carmustine—melanoma	0.00115	0.00122	CcSEcCtD
Dexmethylphenidate—Acute coronary syndrome—Docetaxel—melanoma	0.00115	0.00122	CcSEcCtD
Dexmethylphenidate—Myocardial infarction—Docetaxel—melanoma	0.00114	0.00121	CcSEcCtD
Dexmethylphenidate—Dry mouth—Temozolomide—melanoma	0.00114	0.00121	CcSEcCtD
Dexmethylphenidate—Pain—Bleomycin—melanoma	0.00113	0.0012	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Docetaxel—melanoma	0.00113	0.0012	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Carmustine—melanoma	0.00113	0.0012	CcSEcCtD
Dexmethylphenidate—Tachycardia—Carmustine—melanoma	0.00113	0.0012	CcSEcCtD
Dexmethylphenidate—Confusional state—Temozolomide—melanoma	0.00112	0.0012	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00112	0.0012	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Temozolomide—melanoma	0.00111	0.00119	CcSEcCtD
Dexmethylphenidate—Oedema—Temozolomide—melanoma	0.00111	0.00119	CcSEcCtD
Dexmethylphenidate—Infection—Temozolomide—melanoma	0.00111	0.00118	CcSEcCtD
Dexmethylphenidate—Anorexia—Carmustine—melanoma	0.0011	0.00117	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Docetaxel—melanoma	0.0011	0.00117	CcSEcCtD
Dexmethylphenidate—Epistaxis—Docetaxel—melanoma	0.0011	0.00117	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Temozolomide—melanoma	0.00109	0.00117	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Temozolomide—melanoma	0.00109	0.00116	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Bleomycin—melanoma	0.00109	0.00116	CcSEcCtD
Dexmethylphenidate—Skin disorder—Temozolomide—melanoma	0.00108	0.00115	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Temozolomide—melanoma	0.00108	0.00115	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Dactinomycin—melanoma	0.00107	0.00114	CcSEcCtD
Dexmethylphenidate—SLC6A3—Parkinsons Disease Pathway—APAF1—melanoma	0.00107	0.0193	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—RAI1—melanoma	0.00107	0.0192	CbGpPWpGaD
Dexmethylphenidate—Fatigue—Dactinomycin—melanoma	0.00106	0.00113	CcSEcCtD
Dexmethylphenidate—Anorexia—Temozolomide—melanoma	0.00106	0.00113	CcSEcCtD
Dexmethylphenidate—Pain—Dactinomycin—melanoma	0.00105	0.00112	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Carmustine—melanoma	0.00105	0.00112	CcSEcCtD
Dexmethylphenidate—Urticaria—Bleomycin—melanoma	0.00105	0.00112	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Docetaxel—melanoma	0.00105	0.00112	CcSEcCtD
Dexmethylphenidate—Rhinitis—Docetaxel—melanoma	0.00105	0.00112	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Bleomycin—melanoma	0.00104	0.00111	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Docetaxel—melanoma	0.00104	0.00111	CcSEcCtD
Dexmethylphenidate—Insomnia—Carmustine—melanoma	0.00104	0.00111	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Carmustine—melanoma	0.00104	0.0011	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Docetaxel—melanoma	0.00104	0.0011	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Docetaxel—melanoma	0.00103	0.0011	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Carmustine—melanoma	0.00103	0.0011	CcSEcCtD
Dexmethylphenidate—Somnolence—Carmustine—melanoma	0.00103	0.00109	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Docetaxel—melanoma	0.00103	0.00109	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Docetaxel—melanoma	0.00102	0.00109	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Dactinomycin—melanoma	0.00102	0.00108	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Temozolomide—melanoma	0.00102	0.00108	CcSEcCtD
Dexmethylphenidate—Insomnia—Temozolomide—melanoma	0.00101	0.00108	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Dactinomycin—melanoma	0.00101	0.00107	CcSEcCtD
Dexmethylphenidate—Visual impairment—Docetaxel—melanoma	0.00101	0.00107	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Carmustine—melanoma	0.001	0.00107	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Temozolomide—melanoma	0.001	0.00107	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Carmustine—melanoma	0.000996	0.00106	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Temozolomide—melanoma	0.000994	0.00106	CcSEcCtD
Dexmethylphenidate—Somnolence—Temozolomide—melanoma	0.000991	0.00106	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Docetaxel—melanoma	0.000987	0.00105	CcSEcCtD
Dexmethylphenidate—Pain—Carmustine—melanoma	0.000987	0.00105	CcSEcCtD
Dexmethylphenidate—Constipation—Carmustine—melanoma	0.000987	0.00105	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Temozolomide—melanoma	0.000981	0.00105	CcSEcCtD
Dexmethylphenidate—Eye disorder—Docetaxel—melanoma	0.000975	0.00104	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Dactinomycin—melanoma	0.000974	0.00104	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Dactinomycin—melanoma	0.000974	0.00104	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Bleomycin—melanoma	0.000974	0.00104	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Temozolomide—melanoma	0.000969	0.00103	CcSEcCtD
Dexmethylphenidate—Flushing—Docetaxel—melanoma	0.000969	0.00103	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Docetaxel—melanoma	0.000969	0.00103	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Temozolomide—melanoma	0.000963	0.00103	CcSEcCtD
Dexmethylphenidate—Fatigue—Temozolomide—melanoma	0.000961	0.00102	CcSEcCtD
Dexmethylphenidate—SLC6A3—Alpha-synuclein signaling—PTK2B—melanoma	0.000956	0.0172	CbGpPWpGaD
Dexmethylphenidate—Constipation—Temozolomide—melanoma	0.000953	0.00102	CcSEcCtD
Dexmethylphenidate—Pain—Temozolomide—melanoma	0.000953	0.00102	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Carmustine—melanoma	0.000951	0.00101	CcSEcCtD
Dexmethylphenidate—Asthenia—Bleomycin—melanoma	0.000948	0.00101	CcSEcCtD
Dexmethylphenidate—Angiopathy—Docetaxel—melanoma	0.000947	0.00101	CcSEcCtD
Dexmethylphenidate—CYP2D6—Codeine and Morphine Metabolism—ABCB1—melanoma	0.000945	0.017	CbGpPWpGaD
Dexmethylphenidate—Gastrointestinal pain—Carmustine—melanoma	0.000943	0.00101	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Docetaxel—melanoma	0.000943	0.001	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Docetaxel—melanoma	0.000941	0.001	CcSEcCtD
Dexmethylphenidate—Chills—Docetaxel—melanoma	0.000936	0.000998	CcSEcCtD
Dexmethylphenidate—Pruritus—Bleomycin—melanoma	0.000935	0.000997	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Docetaxel—melanoma	0.000932	0.000994	CcSEcCtD
Dexmethylphenidate—Alopecia—Docetaxel—melanoma	0.000922	0.000983	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Temozolomide—melanoma	0.000919	0.000979	CcSEcCtD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—MAP2—melanoma	0.000917	0.0165	CbGpPWpGaD
Dexmethylphenidate—Mental disorder—Docetaxel—melanoma	0.000914	0.000975	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Carmustine—melanoma	0.000912	0.000972	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Carmustine—melanoma	0.000912	0.000972	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Temozolomide—melanoma	0.000912	0.000972	CcSEcCtD
Dexmethylphenidate—Erythema—Docetaxel—melanoma	0.000908	0.000969	CcSEcCtD
Dexmethylphenidate—Malnutrition—Docetaxel—melanoma	0.000908	0.000969	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Dactinomycin—melanoma	0.000908	0.000968	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.000887	0.016	CbGpPWpGaD
Dexmethylphenidate—Urticaria—Temozolomide—melanoma	0.000886	0.000944	CcSEcCtD
Dexmethylphenidate—Asthenia—Dactinomycin—melanoma	0.000884	0.000943	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Temozolomide—melanoma	0.000881	0.00094	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Temozolomide—melanoma	0.000881	0.00094	CcSEcCtD
Dexmethylphenidate—Back pain—Docetaxel—melanoma	0.000879	0.000937	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Docetaxel—melanoma	0.000873	0.000931	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Carmustine—melanoma	0.00085	0.000906	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Dactinomycin—melanoma	0.000843	0.000899	CcSEcCtD
Dexmethylphenidate—Vomiting—Bleomycin—melanoma	0.00084	0.000896	CcSEcCtD
Dexmethylphenidate—Anaemia—Docetaxel—melanoma	0.00084	0.000895	CcSEcCtD
Dexmethylphenidate—Rash—Bleomycin—melanoma	0.000833	0.000888	CcSEcCtD
Dexmethylphenidate—Dermatitis—Bleomycin—melanoma	0.000833	0.000888	CcSEcCtD
Dexmethylphenidate—Asthenia—Carmustine—melanoma	0.000828	0.000882	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Temozolomide—melanoma	0.000821	0.000876	CcSEcCtD
Dexmethylphenidate—Syncope—Docetaxel—melanoma	0.000815	0.000869	CcSEcCtD
Dexmethylphenidate—Leukopenia—Docetaxel—melanoma	0.000813	0.000867	CcSEcCtD
Dexmethylphenidate—SLC6A3—Alpha-synuclein signaling—SYK—melanoma	0.000813	0.0146	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Monoamine Transport—ITGB3—melanoma	0.000804	0.0145	CbGpPWpGaD
Dexmethylphenidate—Palpitations—Docetaxel—melanoma	0.000803	0.000856	CcSEcCtD
Dexmethylphenidate—Asthenia—Temozolomide—melanoma	0.0008	0.000853	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Docetaxel—melanoma	0.000798	0.000851	CcSEcCtD
Dexmethylphenidate—Cough—Docetaxel—melanoma	0.000793	0.000845	CcSEcCtD
Dexmethylphenidate—SLC6A4—NRF2 pathway—EPHA2—melanoma	0.000791	0.0143	CbGpPWpGaD
Dexmethylphenidate—Diarrhoea—Carmustine—melanoma	0.000789	0.000842	CcSEcCtD
Dexmethylphenidate—Pruritus—Temozolomide—melanoma	0.000789	0.000841	CcSEcCtD
Dexmethylphenidate—Convulsion—Docetaxel—melanoma	0.000787	0.000839	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.000786	0.0142	CbGpPWpGaD
Dexmethylphenidate—Nausea—Bleomycin—melanoma	0.000785	0.000837	CcSEcCtD
Dexmethylphenidate—Hypertension—Docetaxel—melanoma	0.000784	0.000836	CcSEcCtD
Dexmethylphenidate—Vomiting—Dactinomycin—melanoma	0.000784	0.000836	CcSEcCtD
Dexmethylphenidate—Rash—Dactinomycin—melanoma	0.000777	0.000829	CcSEcCtD
Dexmethylphenidate—Arthralgia—Docetaxel—melanoma	0.000773	0.000825	CcSEcCtD
Dexmethylphenidate—Chest pain—Docetaxel—melanoma	0.000773	0.000825	CcSEcCtD
Dexmethylphenidate—Myalgia—Docetaxel—melanoma	0.000773	0.000825	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000768	0.000819	CcSEcCtD
Dexmethylphenidate—Dizziness—Carmustine—melanoma	0.000763	0.000813	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Temozolomide—melanoma	0.000763	0.000813	CcSEcCtD
Dexmethylphenidate—Dry mouth—Docetaxel—melanoma	0.000756	0.000806	CcSEcCtD
Dexmethylphenidate—Confusional state—Docetaxel—melanoma	0.000748	0.000797	CcSEcCtD
Dexmethylphenidate—SLC6A4—NRF2 pathway—SLC6A11—melanoma	0.000744	0.0134	CbGpPWpGaD
Dexmethylphenidate—Anaphylactic shock—Docetaxel—melanoma	0.000741	0.00079	CcSEcCtD
Dexmethylphenidate—Oedema—Docetaxel—melanoma	0.000741	0.00079	CcSEcCtD
Dexmethylphenidate—Dizziness—Temozolomide—melanoma	0.000737	0.000786	CcSEcCtD
Dexmethylphenidate—Infection—Docetaxel—melanoma	0.000737	0.000785	CcSEcCtD
Dexmethylphenidate—Vomiting—Carmustine—melanoma	0.000734	0.000782	CcSEcCtD
Dexmethylphenidate—Nausea—Dactinomycin—melanoma	0.000732	0.000781	CcSEcCtD
Dexmethylphenidate—Shock—Docetaxel—melanoma	0.000729	0.000778	CcSEcCtD
Dexmethylphenidate—Rash—Carmustine—melanoma	0.000727	0.000776	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Docetaxel—melanoma	0.000727	0.000775	CcSEcCtD
Dexmethylphenidate—Dermatitis—Carmustine—melanoma	0.000727	0.000775	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Docetaxel—melanoma	0.000726	0.000774	CcSEcCtD
Dexmethylphenidate—Tachycardia—Docetaxel—melanoma	0.000724	0.000771	CcSEcCtD
Dexmethylphenidate—Headache—Carmustine—melanoma	0.000723	0.000771	CcSEcCtD
Dexmethylphenidate—Skin disorder—Docetaxel—melanoma	0.00072	0.000768	CcSEcCtD
Dexmethylphenidate—Vomiting—Temozolomide—melanoma	0.000709	0.000756	CcSEcCtD
Dexmethylphenidate—Anorexia—Docetaxel—melanoma	0.000707	0.000753	CcSEcCtD
Dexmethylphenidate—Rash—Temozolomide—melanoma	0.000703	0.000749	CcSEcCtD
Dexmethylphenidate—Dermatitis—Temozolomide—melanoma	0.000702	0.000749	CcSEcCtD
Dexmethylphenidate—Headache—Temozolomide—melanoma	0.000698	0.000745	CcSEcCtD
Dexmethylphenidate—SLC6A2—Monoamine Transport—ITGB3—melanoma	0.000691	0.0125	CbGpPWpGaD
Dexmethylphenidate—Nausea—Carmustine—melanoma	0.000685	0.000731	CcSEcCtD
Dexmethylphenidate—SLC6A2—NRF2 pathway—EPHA2—melanoma	0.00068	0.0123	CbGpPWpGaD
Dexmethylphenidate—Musculoskeletal discomfort—Docetaxel—melanoma	0.000675	0.00072	CcSEcCtD
Dexmethylphenidate—Insomnia—Docetaxel—melanoma	0.000671	0.000715	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—MAP2—melanoma	0.000668	0.0121	CbGpPWpGaD
Dexmethylphenidate—Paraesthesia—Docetaxel—melanoma	0.000666	0.00071	CcSEcCtD
Dexmethylphenidate—Nausea—Temozolomide—melanoma	0.000662	0.000706	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Docetaxel—melanoma	0.000661	0.000705	CcSEcCtD
Dexmethylphenidate—Somnolence—Docetaxel—melanoma	0.000659	0.000703	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Docetaxel—melanoma	0.000653	0.000696	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Docetaxel—melanoma	0.000645	0.000687	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Docetaxel—melanoma	0.00064	0.000682	CcSEcCtD
Dexmethylphenidate—SLC6A2—NRF2 pathway—SLC6A11—melanoma	0.000639	0.0115	CbGpPWpGaD
Dexmethylphenidate—Fatigue—Docetaxel—melanoma	0.000639	0.000681	CcSEcCtD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—ARNT—melanoma	0.000634	0.0114	CbGpPWpGaD
Dexmethylphenidate—Constipation—Docetaxel—melanoma	0.000634	0.000676	CcSEcCtD
Dexmethylphenidate—Pain—Docetaxel—melanoma	0.000634	0.000676	CcSEcCtD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—PAX4—melanoma	0.000612	0.011	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Monoamine Transport—ITGB3—melanoma	0.000612	0.011	CbGpPWpGaD
Dexmethylphenidate—Feeling abnormal—Docetaxel—melanoma	0.000611	0.000651	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Docetaxel—melanoma	0.000606	0.000646	CcSEcCtD
Dexmethylphenidate—SLC6A3—NRF2 pathway—EPHA2—melanoma	0.000602	0.0109	CbGpPWpGaD
Dexmethylphenidate—Body temperature increased—Docetaxel—melanoma	0.000586	0.000625	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Docetaxel—melanoma	0.000586	0.000625	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—TP73—melanoma	0.000568	0.0102	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—SLC6A11—melanoma	0.000566	0.0102	CbGpPWpGaD
Dexmethylphenidate—Hypersensitivity—Docetaxel—melanoma	0.000546	0.000582	CcSEcCtD
Dexmethylphenidate—Asthenia—Docetaxel—melanoma	0.000532	0.000567	CcSEcCtD
Dexmethylphenidate—CYP2D6—Tamoxifen metabolism—CYP1B1—melanoma	0.00053	0.00955	CbGpPWpGaD
Dexmethylphenidate—Pruritus—Docetaxel—melanoma	0.000525	0.000559	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Docetaxel—melanoma	0.000507	0.000541	CcSEcCtD
Dexmethylphenidate—Dizziness—Docetaxel—melanoma	0.00049	0.000523	CcSEcCtD
Dexmethylphenidate—Vomiting—Docetaxel—melanoma	0.000471	0.000503	CcSEcCtD
Dexmethylphenidate—Rash—Docetaxel—melanoma	0.000467	0.000498	CcSEcCtD
Dexmethylphenidate—Dermatitis—Docetaxel—melanoma	0.000467	0.000498	CcSEcCtD
Dexmethylphenidate—Headache—Docetaxel—melanoma	0.000464	0.000495	CcSEcCtD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000461	0.00831	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ABCB5—melanoma	0.000446	0.00804	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000444	0.008	CbGpPWpGaD
Dexmethylphenidate—Nausea—Docetaxel—melanoma	0.00044	0.00047	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00044	0.00794	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—CYP1B1—melanoma	0.000409	0.00738	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000408	0.00736	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000403	0.00726	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ABCB5—melanoma	0.000395	0.00712	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000393	0.00709	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000357	0.00644	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—UGT2B10—melanoma	0.000351	0.00633	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—SLC5A5—melanoma	0.00034	0.00613	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—SLC6A11—melanoma	0.000337	0.00608	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—EDN1—melanoma	0.000331	0.00597	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Monoamine Transport—TNF—melanoma	0.000323	0.00582	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—PRKCA—melanoma	0.00031	0.00559	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ARL2—melanoma	0.000309	0.00557	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Dopaminergic Neurogenesis—STAT3—melanoma	0.000299	0.00539	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Parkinsons Disease Pathway—CASP3—melanoma	0.000295	0.00531	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—SLC5A5—melanoma	0.000292	0.00527	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Monoamine Transport—TNF—melanoma	0.000277	0.005	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ARL2—melanoma	0.000274	0.00494	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—GNA11—melanoma	0.000274	0.00493	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000272	0.0049	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—GRIN2A—melanoma	0.000269	0.00485	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000268	0.00484	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—SLC5A5—melanoma	0.000259	0.00467	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—HDAC2—melanoma	0.000257	0.00464	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—GNAQ—melanoma	0.000254	0.00458	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—HGF—melanoma	0.000252	0.00454	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Monoamine Transport—TNF—melanoma	0.000246	0.00443	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL10—melanoma	0.000239	0.0043	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—NGFR—melanoma	0.000235	0.00423	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000234	0.00422	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000229	0.00413	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000226	0.00407	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000226	0.00407	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—AKR1B10—melanoma	0.000223	0.00403	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.00022	0.00397	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—HGF—melanoma	0.000216	0.0039	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000208	0.00374	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GRIN2A—melanoma	0.000206	0.00372	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000205	0.00369	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—HIF1A—melanoma	0.000201	0.00363	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC17A5—melanoma	0.0002	0.0036	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—HGF—melanoma	0.000192	0.00346	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000186	0.00334	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000184	0.00332	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000181	0.00327	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—FAS—melanoma	0.000175	0.00315	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000163	0.00294	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—NFKB1—melanoma	0.00016	0.00289	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—CDK4—melanoma	0.000154	0.00277	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—NOS2—melanoma	0.000149	0.00269	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—PRKCA—melanoma	0.000141	0.00255	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—PPARG—melanoma	0.00014	0.00252	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000131	0.00235	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—CASP3—melanoma	0.000125	0.00225	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.00012	0.00217	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—CYP17A1—melanoma	0.000117	0.00211	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000117	0.00211	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—CYP17A1—melanoma	0.000115	0.00208	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—PRKCA—melanoma	0.000108	0.00195	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000106	0.00191	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—BRAF—melanoma	0.000104	0.00188	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—CYP1B1—melanoma	9.85e-05	0.00178	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	9.72e-05	0.00175	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—PTEN—melanoma	9.58e-05	0.00173	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC5A5—melanoma	9.36e-05	0.00169	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—TNF—melanoma	9.08e-05	0.00164	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—ALB—melanoma	8.79e-05	0.00158	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—MDM2—melanoma	8.72e-05	0.00157	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC5A5—melanoma	8.3e-05	0.0015	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—BRAF—melanoma	7.97e-05	0.00144	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—ALB—melanoma	7.79e-05	0.0014	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL6—melanoma	7.33e-05	0.00132	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ABCB1—melanoma	7.14e-05	0.00129	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—MDM2—melanoma	6.68e-05	0.0012	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ACER3—melanoma	6.57e-05	0.00118	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—TP53—melanoma	6.54e-05	0.00118	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ABCB1—melanoma	6.33e-05	0.00114	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—UGT2B10—melanoma	6.01e-05	0.00108	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—IL6—melanoma	5.99e-05	0.00108	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—MAPK1—melanoma	5.96e-05	0.00107	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—HS3ST5—melanoma	5.59e-05	0.00101	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—HRAS—melanoma	4.78e-05	0.000862	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—MAPK1—melanoma	4.56e-05	0.000823	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ALB—melanoma	4.47e-05	0.000805	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PLCB4—melanoma	4.23e-05	0.000763	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SLC6A11—melanoma	3.98e-05	0.000717	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PIP4K2A—melanoma	3.98e-05	0.000717	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ALB—melanoma	3.96e-05	0.000713	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—MTAP—melanoma	3.87e-05	0.000698	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—HRAS—melanoma	3.66e-05	0.000661	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PHGDH—melanoma	3.45e-05	0.000622	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—LUM—melanoma	3.45e-05	0.000622	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—HPSE—melanoma	3.38e-05	0.00061	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CUBN—melanoma	3.32e-05	0.000599	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CSPG4—melanoma	3.21e-05	0.000578	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SDHD—melanoma	3.21e-05	0.000578	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—BSG—melanoma	3.21e-05	0.000578	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GPAM—melanoma	3.11e-05	0.00056	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PLA2G6—melanoma	2.64e-05	0.000476	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—VCAN—melanoma	2.37e-05	0.000428	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CYP17A1—melanoma	2e-05	0.000361	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GNA11—melanoma	1.89e-05	0.000341	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—FASN—melanoma	1.85e-05	0.000334	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SLC5A5—melanoma	1.82e-05	0.000328	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GNAQ—melanoma	1.76e-05	0.000317	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CD44—melanoma	1.76e-05	0.000317	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CYP1B1—melanoma	1.69e-05	0.000304	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ABCB1—melanoma	1.39e-05	0.00025	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PRKCA—melanoma	1.28e-05	0.00023	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ERCC2—melanoma	1.27e-05	0.000228	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PIK3CG—melanoma	1e-05	0.00018	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PPARG—melanoma	9.65e-06	0.000174	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PIK3CD—melanoma	8.79e-06	0.000159	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ALB—melanoma	8.68e-06	0.000157	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PIK3CB—melanoma	7.66e-06	0.000138	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PTGS2—melanoma	7.59e-06	0.000137	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PTEN—melanoma	6.62e-06	0.000119	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PIK3CA—melanoma	4.67e-06	8.42e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—AKT1—melanoma	3.82e-06	6.88e-05	CbGpPWpGaD
